LWCFA
PRTA icon

Loring Wolcott & Coolidge Fiduciary Advisors’s Prothena Corp PRTA Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-22
Closed – – 635
2016
Q2 		$0 Buy
+22
New +$958 ﹤0.01% 645

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's PRTA Position: Q3 2016 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Prothena Corp (PRTA) in Q3 2016, closing a stake of 22 shares.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in PRTA in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 146 funds tracked by Wall St. Rank hold PRTA as of Q3 2016.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Prothena Corp position as of Q3 2016 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 22 Prothena Corp shares in Q3 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Prothena Corp in Q2 2016 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Prothena Corp position peaked at $0 in Q2 2016.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2016.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2016, filed 1 Nov 2016.